Park Seok Soon, Eom Young-Woo, Kim Eun Hee, Lee Ji Hyun, Min Do Sik, Kim Sungsub, Kim Seong-Jin, Choi Kyeong Sook
Institute for Medical Sciences, Ajou University School of Medicine, 5 Wonchon-Dong, Paldal-Gu, Suwon 442-749, Korea.
Oncogene. 2004 Aug 19;23(37):6272-81. doi: 10.1038/sj.onc.1207856.
Transforming growth factor-beta1 (TGF-beta1) is a potent inducer of apoptosis in normal hepatocytes, and acquiring resistance to TGF-beta1 may be a critical step in the development of hepatocellular carcinoma (HCC). In this study, we investigated the possible involvement of c-Src in the regulation of TGF-beta1-induced apoptosis. TGF-beta1 induced transient activation of c-Src and its subsequent caspase-mediated degradation concomitant with cell death in FaO hepatoma cells, which are sensitive to TGF-beta1. In response to TGF-beta1, activated c-Src was translocated into the cytoplasmic membrane, then relocated to the nuclei of apoptotic cells during its cleavage. In TGF-beta1-induced apoptotic cells, c-Src maintained its tight association with p85 FAK fragment cleaved by caspases, possibly contributing to focal adhesion disassembly. TGF-beta1-induced apoptosis was enhanced by either inhibition of c-Src activity using PP1 or PP2, or by overexpression of dominant-negative c-Src. In contrast, overexpression of constitutively active c-Src inhibited apoptosis suppressing TGF-beta1-induced activation of p38, JNK and caspases. In many HCC cell lines resistant to TGF-beta1, enhanced c-Src activity was detected. We hypothesize that activated c-Src in HCC may contribute to resistance against the apoptotic and/ or antiproliferative properties of TGF-beta1.
转化生长因子-β1(TGF-β1)是正常肝细胞凋亡的强效诱导剂,而获得对TGF-β1的抗性可能是肝细胞癌(HCC)发生发展的关键步骤。在本研究中,我们调查了c-Src在TGF-β1诱导的凋亡调控中的可能作用。TGF-β1可诱导对TGF-β1敏感的FaO肝癌细胞中c-Src的瞬时激活及其随后的半胱天冬酶介导的降解,并伴随细胞死亡。响应TGF-β1时,活化的c-Src转位至细胞质膜,然后在其裂解过程中重新定位于凋亡细胞的细胞核。在TGF-β1诱导的凋亡细胞中,c-Src与被半胱天冬酶切割的p85 FAK片段保持紧密结合,这可能有助于粘着斑的解体。使用PP1或PP2抑制c-Src活性,或过表达显性负性c-Src均可增强TGF-β1诱导的凋亡。相反,组成型活性c-Src的过表达抑制凋亡,抑制TGF-β1诱导的p38、JNK和半胱天冬酶的激活。在许多对TGF-β1耐药的HCC细胞系中,检测到c-Src活性增强。我们推测,HCC中活化的c-Src可能有助于抵抗TGF-β1的凋亡和/或抗增殖特性。